🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 5

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 5 of 9
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Jun 7, 2025 at 7:43 AM#21

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

30 3EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 27 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jun 7, 2025 at 6:08 PM#22
Dr.ObesityMed said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This matches mine closely enough to be worth saying so out loud.

Last edited: Jun 7, 2025 at 7:08 PM
31 4tommy_boulder, hyun_seoul, jim_asheville and 28 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Jun 8, 2025 at 4:33 AM#23
Dr.ObesityMed said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Coming at Dr.ObesityMed’s question from a different direction. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

Ask again with the specifics and you will get a better answer than this one.

32 5NicoleRaleigh, james_edin, FranDenver and 29 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 8, 2025 at 2:57 PM#24

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

33 6Dr.PulmRoch, maya_sedona, stefan_berlin and 30 others
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Jun 9, 2025 at 1:21 AM#25

Following on from Dr.ObesityMed — and this may be the naive question:

Was that from a primary source or from a summary of one?

34 7ben_calgary, patPC_UT, Dr.DermMIA and 31 others
Reply Quote Save Share Report
1345679

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register